Recurrent glioblastoma (GBM) or High-Grade Glioma (HGG) remains one of the most challenging neuro-oncological conditions, with limited survival benefit from conventional therapies. Emerging molecularly targeted approaches, particularly Lutetium-177–based peptide receptor radionuclide therapy (PRRT), are showing promise as innovative strategies for select…
RadioiodineTherapy(I-131)forThyroidCancer: How It Works and Who Needs It
Radioiodine Therapy, commonly known as iodine 131 treatment, is an important part ofmodern thyroid cancer treatment and is widely used in advanced nuclear medicine in India.This therapy is especially recommended after thyroid surgery to destroy any remainingthyroid tissue or microscopic cancer…
Lutetium vs Actinium: Choosing the Right Alpha or Beta Strategy
Lutetium-177 and Actinium-225 therapies are transforming precision cancer treatment in India, especially for advanced and metastatic prostate cancer. In recent years, targeted radionuclide therapy has emerged as one of the most advanced treatment options for complex cancers. A common question among…
Terbium-161 FAPI Therapy: A New Frontier for Hard-to-Treat Cancers
When cancer comes back after treatment—or doesn’t respond at all—it can feel like the options are running out. But science is moving fast, and a new therapy called Terbium-161 FAPI is offering fresh hope to patients with relapsed or refractory solid…
🌟 Terbium-161 DOTATATE: A New Option for Neuroendocrine Tumors That Resist Standard Treatment
Living with a neuroendocrine tumor (NET) can be a long journey filled with ups and downs. For many patients, Lutetium-177 DOTATATE (Lu-177 PRRT) has been a game-changer—slowing tumor growth and improving quality of life. But what happens when the tumor stops…
Terbium-161 PSMA Therapy: A New Hope for Advanced Prostate Cancer Patients Resistant to Lutetium-177 PSMA
For many men battling advanced prostate cancer, modern treatments like Lutetium-177 PSMA therapy have brought relief and extended life. But what happens when the cancer stops responding? That’s where a new therapy “Terbium-161 PSMA” is stepping in, offering fresh hope for…
India’s 1st Radium-223 Therapy for Advanced Prostate Cancer Now Available at Theranostics Centre a unit of Sarvodaya Hospital
Sarvodaya Cancer Hospital Delhi NCR proudly announces the first-time availability of Radium-223 therapy in India for patients with castration-resistant prostate cancer (CRPC) and predominant skeletal metastases. This milestone marks a new era in precision oncology, offering hope to patients with advanced…
A New Ray of Hope: Terbium-161 Therapy Now Available at Theranostics Centre a unit of Sarvodaya Hospital
Theranos Care unit of Sarvodaya Hospital, Faridabad has become the first center in the Indian subcontinent to offer Terbium-161 therapy in India for patients with metastatic castration-resistant prostate cancer (mCRPC) and metastatic neuroendocrine tumors (NET) who have not responded to Lutetium-PSMA…
Neuroendocrine Tumors: Symptoms, Causes, Risk Factors & Treatment
Neuroendocrine tumors (NETs) are a rare group of cancers that can grow in different parts of the body. They start in special cells called “neuroendocrine cells”, which help control how your body works by releasing hormones. These cells are found in…
Peptide Receptor Radionuclide Therapy PRRT Role in Neuroendocrine Cancer treatment
A Targeted Breakthrough in Treating Neuroendocrine Tumors By Using PRRT Being diagnosed with a neuroendocrine tumor (NET) can feel confusing and overwhelming. These rare tumors often grow slowly and may not cause symptoms for years. But when they do, they can…